On the admissibility of Biological Equivalence Tests during the patent term for obtaining a regulatory approval for patented drugs by third parties : a study in German and comparative / Joseph Straus.

On the admissibility of Biological Equivalence Tests during the patent term for obtaining a regulatory approval for patented drugs by third parties : a study in German and comparative / Joseph Straus.

Journal article

1 volume ([35] pages) ; [28] cm.

2 JP

- The issue of admissibility of clinical trials related to pharmaceutically active ingredients petented to third parties and eventually aimed also at obtaining regulatory marketing authorization since some years has attracted enormous attention. This is witnessed by a remarkable number of court decisions handed down in various countries, by numerous articles published in leading law and economic journals, as well as by legal actions initiated with the World Trade Organization (WTO);.

Journal Of The Japanese Group Of Aippi (International Edition) ; 1998 Vol 23 No 6 pages 211-246.

Tokyo [Japan] : International Association for the Protection of Intellectual Property (AIPPI), 1999.

eng